These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 4784788)

  • 21. [Comparative studies on the metabolism of xylitol, sorbitol, and fructose in humans].
    Keller U; Froesch ER
    Schweiz Med Wochenschr; 1972 Jul; 102(29):1017-22. PubMed ID: 5048761
    [No Abstract]   [Full Text] [Related]  

  • 22. [The reaction of lipids to parenteral administration of carbohydrates].
    Matzkies F; Berg G
    Infusionstherapie (1973); 1974 Oct; 1(7):545-7. PubMed ID: 4219389
    [No Abstract]   [Full Text] [Related]  

  • 23. [Metabolic side effects with the use of carbohydrates].
    Behrendt W
    Beitr Infusionsther; 1990; 25():188-204. PubMed ID: 1690045
    [No Abstract]   [Full Text] [Related]  

  • 24. [Increase of plasma uric acid concentration after oral administration of fructose, sorbit and xylit].
    Förster H; Ziege M
    Z Ernahrungswiss; 1971 Dec; 10(4):394-6. PubMed ID: 5161177
    [No Abstract]   [Full Text] [Related]  

  • 25. [Recommendations for the use of carbohydrates in the infusion therapy].
    Berg G
    Z Ernahrungswiss; 1975 Dec; 14(4):345-52. PubMed ID: 1229169
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Glucose or sugar substitutes in parenteral infusions? The choice of carbohydrates in postoperative infusion therapy].
    Leutenegger AF
    Fortschr Med; 1980 Dec; 98(47-48):1864-6. PubMed ID: 6783495
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Comparative studies during postoperative infusion of glucose or a combination of glucose, fructose and xylitol over five days (author's transl)].
    Göschke H; Leutenegger AF; Mannhart H; Stutz K; Werdenberg D; Allgöwer M
    Klin Wochenschr; 1977 Nov; 55(22):115-9. PubMed ID: 412995
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Infusion solutions with fructose and sorbitol].
    Froesch ER
    Dtsch Med Wochenschr; 1983 Dec; 108(51-52):l983. PubMed ID: 6653429
    [No Abstract]   [Full Text] [Related]  

  • 29. [On the nutrition of tetanus patients].
    Schultis K; L'Allemand H
    Anaesthesist; 1968 Jun; 17(6):196-201. PubMed ID: 4973500
    [No Abstract]   [Full Text] [Related]  

  • 30. [Parenteral feeding].
    Hartig W
    Z Gesamte Inn Med; 1973 Oct; 28(19):585-91. PubMed ID: 4203172
    [No Abstract]   [Full Text] [Related]  

  • 31. [Carbohydrate infusions in internal diseases. A comparative study in metabolically healthy, liver diseased and diabetic patients. VIII. Continuous infusions of low dosage carbohydrate mixtures in patients with liver cirrhosis].
    Egberts EH; Müller PH
    Infusionsther Klin Ernahr; 1982 Aug; 9(4):166-85. PubMed ID: 6813263
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The comparative oxidation of glucose, fructose, sorbitol and xylitol in normal man.
    Pellaton M; Acheson K; Maeder E; Jequier E; Felber JP
    JPEN J Parenter Enteral Nutr; 1978 Nov; 2(5):627-33. PubMed ID: 571926
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Glucose substitutes in parenteral nutrition].
    Keller U
    Dtsch Med Wochenschr; 1995 Mar; 120(11):384. PubMed ID: 7889822
    [No Abstract]   [Full Text] [Related]  

  • 34. Fatty liver in rats following parenteral hyperalimentation with glucose or glucose substitutes.
    Machytka B; Hoos I; Förster H
    Nutr Metab; 1977; 21 Suppl 1():110-2. PubMed ID: 411069
    [No Abstract]   [Full Text] [Related]  

  • 35. Water, electrolytes, vitamins and carbohydrates in parenteral nutrition.
    Thorén L
    Acta Anaesthesiol Scand Suppl; 1974; 55():123-6. PubMed ID: 4217081
    [No Abstract]   [Full Text] [Related]  

  • 36. [Current calorie value of intravenous infusion of nutritional solutions].
    Halmágyi M; Fauth U; Heinrichs W; Tzanova I
    Infusionstherapie; 1989 Aug; 16 Suppl 1():44-8. PubMed ID: 2511154
    [No Abstract]   [Full Text] [Related]  

  • 37. [Utilisation and metabolic behaviour of sorbitol during long-term parenteral perfusions (author's transl)].
    Bickel H; Matzkies F; Fekl W; Berg G
    Dtsch Med Wochenschr; 1973 Nov; 98(44):2079-83. PubMed ID: 4202269
    [No Abstract]   [Full Text] [Related]  

  • 38. [The sugar substitutes fructose and sorbite: an unnecessary risk in parenteral nutrition].
    Keller U
    Schweiz Med Wochenschr; 1989 Jan; 119(4):101-6. PubMed ID: 2493157
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Short review on intensive parenteral carbohydrate therapy].
    Bervar M
    Vojnosanit Pregl; 1973; 30(5):372-4. PubMed ID: 4204073
    [No Abstract]   [Full Text] [Related]  

  • 40. [Parenteral administration of sugar substitutes with special reference to diabetes mellitus].
    Haslbeck M
    Infusionstherapie (1973); 1974 Oct; 1(7):569-76. PubMed ID: 4219396
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.